JNJ

J&J scores third appeals win—this one for $55M—in talc powder litigation
J&J scores third appeals win—this one for $55M—in talc powder litigation
Fierce Pharma
JNJ
Flag link:
Amgen Announces Top-Line Data From Remicade Biosimilar Study
Amgen Announces Top-Line Data From Remicade Biosimilar Study
Yahoo/Zacks.com
Amgen
ABP 710
JNJ
Merck
Remicade
biosimilars
rheumatoid arthritis
Flag link:
Dare to 'Dreem': J&J Invests in Sleep-Focused Medtech Startup
Dare to 'Dreem': J&J Invests in Sleep-Focused Medtech Startup
Medical Devices and Diagnostics Industry
Dreem
JNJ
devices
neurotech
Flag link:
ADA: J&J's Invokana and rivals cut heart failure hospitalizations without increasing amputation risk
ADA: J&J's Invokana and rivals cut heart failure hospitalizations without increasing amputation risk
Fierce Pharma
JNJ
Invokana
diabetes
heart failure
Flag link:
J&J's Drug Unit Chief Expands Portfolio in Executive Shakeup
J&J's Drug Unit Chief Expands Portfolio in Executive Shakeup
Yahoo/Bloomberg
JNJ
Joaquin Duato
reorganization
Flag link:
Johnson & Johnson hits the Big Apple with latest JLabs site
Johnson & Johnson hits the Big Apple with latest JLabs site
Mass Device
JNJ
New York
NYC
incubators
innovation
Flag link:
New York Judge's Ruling Could Be Painful For Opioid-Makers Sued Over Addiction Crisis
New York Judge's Ruling Could Be Painful For Opioid-Makers Sued Over Addiction Crisis
Forbes
New York
opioids
opioid crisis
Purdue Pharma
JNJ
Flag link:
After split from Actelion, Idorsia CEO plans to raise more cash in 2019
After split from Actelion, Idorsia CEO plans to raise more cash in 2019
Yahoo/Reuters
Indorsia
Actelion
JNJ
insomnia
Flag link:
Novartis touts effectiveness, safety of autoimmune drug copies
Novartis touts effectiveness, safety of autoimmune drug copies
Yahoo/Reuters
Novartis
biosimilars
JNJ
Remicade
Amgen
Enbrel
autoimmune disease
Flag link:
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
CP Wire
JNJ
NICE
Tremfya
psoriasis
Flag link:
Johnson & Johnson’s Tremfya Approved for Reimbursement in the UK and Germany
JNJ
Tremfya
psoriasis
Flag link:
Johnson & Johnson OKs $2B LifeScan sale to Platinum Equity
Johnson & Johnson OKs $2B LifeScan sale to Platinum Equity
Drug Delivery Business News
JNJ
M&A
LifeScan
blood glucose monitoring
devices
Flag link:
Is There an End in Sight for J&J Divestitures?
Is There an End in Sight for J&J Divestitures?
Medical Devices and Diagnostics Industry
JNJ
M&A
LifeScan
Fortive
devices
Flag link:
J&J gets $2.7 billion offer for sterilization unit from Fortive
J&J gets $2.7 billion offer for sterilization unit from Fortive
Yahoo/Reuters
JNJ
Fortive
M&A
sterilzation
Ethicon
Flag link:
J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety
J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety
Endpoints
JNJ
esketamine
major depression
Flag link:
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
Endpoints
M&A
JNJ
Merck
Pfizer
Gilead Sciences
Amgen
Biogen
Takeda
Regeneron
Alexion
Flag link:
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results
Roche Up, J&J Down as Cancer Drug Combos Yield More Mixed Results
Xconomy
clinical trials
Roche
Genentech
Genmab
JNJ
cancer
Tecentriq
Darzalex
Flag link:
Danish biotech Genmab hit by ending of trial using key cancer drug
Danish biotech Genmab hit by ending of trial using key cancer drug
Reuters
Genmab
JNJ
Janssen
Darzalex
Flag link:
Biopharma M&A: You Ain’t Seen Nothing Yet
Biopharma M&A: You Ain’t Seen Nothing Yet
Barron's
JNJ
Merck
Pfizer
Gilead Sciences
Amgen
Regeneron
Alexion
M&A
Flag link:
Johnson & Johnson suffers another cancer-suit loss as talc case count climbs above 9,000
Johnson & Johnson suffers another cancer-suit loss as talc case count climbs above 9,000
Fierce Pharma
JNJ
lawsuit
mesothelioma
Flag link:

Pages